These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Paraneoplastic syndromes: concept and limits. Viewpoint of the internist and the dermatologist]. Gilsanz García V; Gómez Orbaneja J An R Acad Nac Med (Madr); 1985; 102(4):353-84. PubMed ID: 3832962 [No Abstract] [Full Text] [Related]
28. [Paraneoplastic syndromes. Their significance in the early diagnosis of cancer by the general practitioner]. Clément F Praxis; 1969 Mar; 58(12):365-72. PubMed ID: 5818675 [No Abstract] [Full Text] [Related]
29. Gastrointestinal endocrine tumours. Stadil F Ann Chir Gynaecol; 1983; 72(3):177-81. PubMed ID: 6137992 [No Abstract] [Full Text] [Related]
33. [Endocrine pancreas tumors. Progress in diagnosis and surgical therapy]. Heberer G; Teichmann RK MMW Munch Med Wochenschr; 1982 Oct; 124(43):945-7. PubMed ID: 6292707 [No Abstract] [Full Text] [Related]
34. [Comments on the contribution by U. Kaboth and W. Hiddemann. Paraneoplastic syndromes]. Tuschy U Internist (Berl); 1995 May; 36(5):523. PubMed ID: 7601627 [No Abstract] [Full Text] [Related]
35. Endocrinology and the surgeon. Reeve TS Aust N Z J Surg; 1978 Jun; 48(3):235-6. PubMed ID: 281212 [No Abstract] [Full Text] [Related]
37. Ophthalmic manifestations of endocrine disorders: approaches and medical management. Hendrick AM; Kahook MY; Daoud YJ; Hazin R Curr Opin Ophthalmol; 2009 Nov; 20(6):495-503. PubMed ID: 19752729 [TBL] [Abstract][Full Text] [Related]
38. Ectopic secretion of calcitonin as a tumor marker (review). Mulder H Anticancer Res; 1983; 3(4):247-50. PubMed ID: 6192753 [TBL] [Abstract][Full Text] [Related]
39. Endocrine manifestations of cancer and its treatment. Shalet SM Practitioner; 1981 Jun; 225(1356):829-36. PubMed ID: 7301756 [No Abstract] [Full Text] [Related]